Orion Corporation

Orion Corporation, trading as Orion Pharma, is a Nordic pharmaceutical company headquartered in Espoo, Finland. Founded in 1917, it develops, manufactures and markets human and veterinary pharmaceuticals, self-care products, animal well-being products and active pharmaceutical ingredients. The company employs approximately 3,000 professionals worldwide and is listed on the Helsinki Stock Exchange.

Its prescription pharmaceutical portfolio spans oncology, respiratory diseases, neurological diseases, women's health and pain management, and is delivered to patients in over 100 countries. In addition to human medicines, the group sells veterinary medicines, an over-the-counter self-care range and products supporting animal health and well-being, and manufactures active pharmaceutical ingredients at its own production facilities in Finland. Research and development is conducted in-house, with a pipeline of innovative treatments.

The company's stated purpose is to build well-being by helping societies address unmet medical needs, with an emphasis on making high-quality medicines accessible and affordable in order to strengthen healthcare systems. Its operations are concentrated in Finland and the wider Nordic region, with distribution reaching more than 100 countries.